Gas chromatographic-mass spectrometric procedures for determination of the catechol-O-methyltransferase (COMT) activity and for detection of unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascendi derivatization using S-adenosylmethionine

被引:24
作者
Maurer, HH [1 ]
Bickeboeller-Friedrich, J [1 ]
Kraemer, T [1 ]
机构
[1] Univ Saarland, Inst Pharmacol & Toxicol, Dept Toxicol, D-66421 Homburg, Saar, Germany
来源
JOURNAL OF CHROMATOGRAPHY B | 2000年 / 739卷 / 02期
关键词
enzymes; catechol-O-methyltransferase; 3,4-dihydroxyphenethylamine;
D O I
10.1016/S0378-4347(00)00025-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A procedure is presented for determination of the catechol-O-methyltransferase (COMT) activity in liver cytosolic preparations using 3,4-dihydroxyphenethylamine as substrate and by quantifying the product 3-methoxy-4-hydroxyphenethylamine (3-MHP). For quantification of 3-MHP in liver cytosolic preparations a gas chromatographic-mass spectrometric procedure after liquid-liquid extraction and acetylation was established and validated. The intra- and inter-day accuracy and precision were better than 15% and 20%, respectively. Extraction efficiency and selectivity were also sufficient. For in statu nascendi derivatization of unstable catecholic metabolites in liver microsome preparations, cytosolic preparations with COMT activities of at least 1 nmol product/min/mg protein were used after addition of S-adenosylmethionine. Such catecholic metabolites, which are claimed to be responsible for toxic effects in vivo, e.g., neurotoxicity or carcinogenesis, must not be overlooked in in vitro metabolism studies. Using this trick, gas chromatography-mass spectrometry (GC-MS) was suitable for the determination of catecholic metabolites in human and rat liver preparations after the same sample preparation as for 3-MHP quantification. The applicability was exemplified for the antidepressant paroxetine. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:325 / 335
页数:11
相关论文
共 22 条
[1]  
BICKEBOELLERFRI.J, 1999, P 1998 JOINT SOFT TI, P340
[2]  
BICKEBOELLERFRI.J, 1998, ARCH PHARM PHARM MED, V331, P62
[3]  
Borchardt R T, 1981, Methods Enzymol, V77, P267
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Catechol-O-methyltransferase:: variation in enzyme activity and inhibition by entacapone and tolcapone [J].
De Santi, C ;
Giulianotti, PC ;
Pietrabissa, A ;
Mosca, F ;
Pacifici, GM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :215-219
[6]   Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, ''Eve'') and its metabolites in urine by gas chromatography mass spectrometry and fluorescence polarization immunoassay [J].
Ensslin, HK ;
Kovar, KA ;
Maurer, HH .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 683 (02) :189-197
[7]  
Ensslin HK, 1996, DRUG METAB DISPOS, V24, P813
[8]  
HIRAMATSU M, 1990, J PHARMACOL EXP THER, V254, P521
[9]   VALIDATION OF BIOANALYTICAL METHODS [J].
KARNES, HT ;
SHIU, G ;
SHAH, VP .
PHARMACEUTICAL RESEARCH, 1991, 8 (04) :421-426
[10]   ASSAY OF CATECHOL O-METHYLTRANSFERASE ACTIVITY BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
KOH, S ;
ARAI, M ;
KAWAI, S ;
OKAMOTO, M .
JOURNAL OF CHROMATOGRAPHY, 1981, 226 (02) :461-465